Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors-Reference-Cited by-同舟云学术

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

Published:2016-05-01 Issue:5 Volume:2 Page:616
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Parsons D. Williams¹,Roy Angshumoy²,Yang Yaping³,Wang Tao⁴,Scollon Sarah⁵,Bergstrom Katie⁵,Kerstein Robin A.⁵,Gutierrez Stephanie⁵,Petersen Andrea K.³,Bavle Abhishek⁵,Lin Frank Y.⁶,López-Terrada Dolores H.²,Monzon Federico A.⁷,Hicks M. John²,Eldin Karen W.⁷,Quintanilla Norma M.⁷,Adesina Adekunle M.⁸,Mohila Carrie A.⁷,Whitehead William⁹,Jea Andrew⁹,Vasudevan Sanjeev A.¹⁰,Nuchtern Jed G.¹¹,Ramamurthy Uma¹²,McGuire Amy L.¹³,Hilsenbeck Susan G.⁴,Reid Jeffrey G.¹⁴,Muzny Donna M.¹⁴,Wheeler David A.¹⁵,Berg Stacey L.⁶,Chintagumpala Murali M.⁶,Eng Christine M.³,Gibbs Richard A.¹⁶,Plon Sharon E.¹

Affiliation:

1. Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas3The Human Genome Sequencing Center, Baylor College of Medicine, Houston, T

2. Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston4The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas5Department of Pathology, Texas Children’s Hospital, Houston6Department of Pathology a

3. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas

4. The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas

5. Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston

6. Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston4The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas

7. Department of Pathology, Texas Children’s Hospital, Houston6Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas

8. The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas5Department of Pathology, Texas Children’s Hospital, Houston6Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas

9. Division of Pediatric Neurosurgery, Department of Neurosurgery, Baylor College of Medicine, Houston, Texas8Department of Surgery, Texas Children’s Hospital, Houston

10. The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas8Department of Surgery, Texas Children’s Hospital, Houston9Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas

11. Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston4The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas8Department of Surgery, Texas Children’s Hospital, Houston9Michael E. DeBakey Departme

12. Dan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas

13. The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas11Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas

14. The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas

15. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas3The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas4The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas

16. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas3The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 349 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?;Genetics in Medicine;2024-02

2. Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics;Genetics in Medicine;2024-02

3. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers;Frontiers in Immunology;2024-01-22

4. Comparing variants related to chronic diseases from genome-wide association study (GWAS) and the cancer genome atlas (TCGA);BMC Medical Genomics;2023-12-19

5. Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients;Cancer Research Communications;2023-11-14